Skip to Main Content

Author Details

Hui Shen
Van Andel Institute
2010
68
45
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36928921A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.Clin Cancer Res2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
37461447A Novel Humanized Immune Stroma PDX Cancer Model for Therapeutic Studies.bioRxiv2023
36948185Epigenetic dosage identifies two major and functionally distinct β cell subtypes.Cell Metab2023
37380777Cancer aneuploidies are shaped primarily by effects on tumour fitness.Nature2023
36928921A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.Clin Cancer Res2023
36459996Subclonal mutations in epigenetic regulators bring fitness in times of stress.Cancer Cell2023
37461447A Novel Humanized Immune Stroma PDX Cancer Model for Therapeutic Studies.bioRxiv2023
36948185Epigenetic dosage identifies two major and functionally distinct β cell subtypes.Cell Metab2023
37380777Cancer aneuploidies are shaped primarily by effects on tumour fitness.Nature2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
36459996Subclonal mutations in epigenetic regulators bring fitness in times of stress.Cancer Cell2023
36347867Cell division drives DNA methylation loss in late-replicating domains in primary human cells.Nat Commun2022
35654826Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1.Commun Biol2022
36347867Cell division drives DNA methylation loss in late-replicating domains in primary human cells.Nat Commun2022
35873672DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse.Cell Genom2022
36066972Transcriptome and DNA methylome analyses reveal underlying mechanisms for the racial disparity in uterine fibroids.JCI Insight2022
36402747PRDM15 interacts with DNA-PK-Ku complex to promote radioresistance in rectal cancer by facilitating DNA damage repair.Cell Death Dis2022
35654826Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1.Commun Biol2022
36402747PRDM15 interacts with DNA-PK-Ku complex to promote radioresistance in rectal cancer by facilitating DNA damage repair.Cell Death Dis2022
35873672DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse.Cell Genom2022
36066972Transcriptome and DNA methylome analyses reveal underlying mechanisms for the racial disparity in uterine fibroids.JCI Insight2022
32339229The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.J Natl Cancer Inst2021
32339229The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.J Natl Cancer Inst2021
34147133Evaluation of whole-genome DNA methylation sequencing library preparation protocols.Epigenetics Chromatin2021
33217343Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.Cancer Cell2021
34147133Evaluation of whole-genome DNA methylation sequencing library preparation protocols.Epigenetics Chromatin2021
33217343Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.Cancer Cell2021
32641237Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.Gynecol Oncol2020
32641237Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.Gynecol Oncol2020
33296650Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis.Cell Rep2020
35117726The efficacy of afatinib in patients with <i>HER2</i> mutant non-small cell lung cancer: a meta-analysis.Transl Cancer Res2020
35117726The efficacy of afatinib in patients with <i>HER2</i> mutant non-small cell lung cancer: a meta-analysis.Transl Cancer Res2020
33296650Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis.Cell Rep2020
31037156Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).Theranostics2019
31851934Integrated Epigenome, Exome, and Transcriptome Analyses Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids.Cell Rep2019
31037156Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).Theranostics2019
31433971The Immune Landscape of Cancer.Immunity2019
31391455ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.Nat Commun2019
31851934Integrated Epigenome, Exome, and Transcriptome Analyses Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids.Cell Rep2019
31433971The Immune Landscape of Cancer.Immunity2019
31391455ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.Nat Commun2019
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
29925010The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
30085201SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions.Nucleic Acids Res2018
29898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018
29535383A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.Nat Commun2018
29625050Oncogenic Signaling Pathways in The Cancer Genome Atlas.Cell2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
29617669The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
  • 1 - 50 of 136

Recommended Authors

Tiago C Silva
University of Miami Miller School of Medicine
Career Start Year 2016
Number of shared co-authors 29
Jing Li
Center for Translational Medicine, Second Military Medical University
Career Start Year 2014
Number of shared co-authors 0
Ankur Chakravarthy
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 5
Paul Guilhamon
The Hospital for Sick Children
Career Start Year 2013
Number of shared co-authors 3
Pavlo Lutsik
Catholic University (KU) Leuven
Career Start Year 2010
Number of shared co-authors 2
Lukas Chavez
University of California San Diego
Career Start Year 2008
Number of shared co-authors 3
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 9
Leander Van Neste
Maastricht University Medical Center
Career Start Year 2007
Number of shared co-authors 6
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 8
Eleni M Tomazou
St. Anna Children's Cancer Research Institute (CCRI)
Career Start Year 2007
Number of shared co-authors 2
Yassen Assenov
German Cancer Research Center (DKFZ)
Career Start Year 2006
Number of shared co-authors 3
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 40
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Career Start Year 2006
Number of shared co-authors 13
Brock C Christensen
Geisel School of Medicine, Dartmouth College
Career Start Year 2005
Number of shared co-authors 17
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2005
Number of shared co-authors 22
David Klinkebiel
University of Nebraska Medical Center
Career Start Year 2005
Number of shared co-authors 0
Duncan Sproul
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2004
Number of shared co-authors 4
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 23
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 41
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 8
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 51
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 11
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 0
Martin Hirst
University of British Columbia
Career Start Year 1998
Number of shared co-authors 55
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Career Start Year 1997
Number of shared co-authors 11
Joseph F Costello
University of California san francisco
Career Start Year 1991
Number of shared co-authors 40
Holger Heyn
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year 1988
Number of shared co-authors 25
Christoph Plass
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 15

Collaborators

Peter W Laird
Van Andel Institute
Co-authored papers 43
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 17
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 12
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 11
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Daniel J Weisenberger
Co-authored papers 11
Wanding Zhou
University of Pennsylvania
Co-authored papers 10
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 10
Reanne Bowlby
Co-authored papers 10
Matthew Meyerson
Broad Institute
Co-authored papers 8
David A Wheeler
Baylor College of Medicine
Co-authored papers 8
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Huihui Fan
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers 8
Toshinori Hinoue
Co-authored papers 8
Christina Yau
University of California San Francisco
Co-authored papers 7
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 7
Charles M Perou
Co-authored papers 7
Rameen Beroukhim
Co-authored papers 7
Jay Bowen
Nationwide Children's Hospital
Co-authored papers 6
David Van Den Berg
Co-authored papers 6
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Houtan Noushmehr
Henry Ford Hospital
Co-authored papers 6
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers 6
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 6
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 6
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 6
Christopher C Benz
Buck Institute for Research on Aging
Co-authored papers 6
James J Hsieh
Washington University
Co-authored papers 5
Scott L Carter
Co-authored papers 5
Release 1.2